Back to User profile » Dr Xiaobin Zheng
Papers published by Dr Xiaobin Zheng:
Epidemiological, Clinical, Laboratorial and CT Imaging Features of Hospitalized Patients with Initially Negative Detection of SARS-CoV-2 in China
Liang Y, Zheng X, Chen M, Tu C, Tan C, Huang Y, Wang Z, Wu J, Liu J
International Journal of General Medicine 2021, 14:8039-8046
Published Date: 10 November 2021
Trend in Antimicrobial Resistance of Staphylococcus aureus: Results from the China Antimicrobial Surveillance Network (CHINET) in the Last 15-Year-Period Reports (2005–2019) [Retraction]
Liang Y, Qiu L, Zheng X, Liu J
Infection and Drug Resistance 2021, 14:4215-4216
Published Date: 19 October 2021
Trend in Antimicrobial Resistance of Staphylococcus aureus: Results from the China Antimicrobial Surveillance Network (CHINET) in the Last 15-Year-Period Reports (2005–2019)
Liang Y, Qiu L, Zheng X, Liu J
Infection and Drug Resistance 2021, 14:2179-2181
Published Date: 10 June 2021
Co-Occurrence of mcr-9 and blaNDM-1 in Enterobacter cloacae Isolated from a Patient with Bloodstream Infection
Lin M, Yang Y, Yang Y, Chen G, He R, Wu Y, Zhong LL, El-Sayed Ahmed MAEG, Feng S, Shen C, Wen X, Huang J, Li H, Zheng X, Tian GB
Infection and Drug Resistance 2020, 13:1397-1402
Published Date: 12 May 2020
Co-production of MCR-1 and NDM-5 in Escherichia coli isolated from a colonization case of inpatient
Feng S, Shen C, Chen H, Zheng X, Xia Y, Zhong LL, Huang X, Wu X, Tian GB
Infection and Drug Resistance 2018, 11:1157-1161
Published Date: 14 August 2018
Decreased frequency of adenoidectomy by a 12-week nasal budesonide treatment
Hong H, Chen F, Zheng X, Liao W, Liao Z, Cao Y, He H, Zhu Z, Fan Y
Therapeutics and Clinical Risk Management 2017, 13:1309-1316
Published Date: 3 October 2017